ArticleInternational journal of rheumatology2012

Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus.

Ryusuke Yoshimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.